Enhanced productivity of gamma-amino butyric acid by cascade modifications of a whole-cell biocatalyst

• Published in: Applied microbiology and biotechnology 2018-04, Vol.102 (8), p.3623-3633
• Main Authors: Yang, Xinwei, Ke, Chongrong, Zhu, Jiangming, Wang, Yan, Zeng, Wenchao, Huang, Jianzhong
• Format: Article
• Language: English
• Subjects: Amino acids; Biocatalysts; Bioconversion; Biomedical and Life Sciences; Bioreactors; Biotechnological Products and Process Engineering; Biotechnology; Butyric acid; Chaperones; Deactivation; Decarboxylation; Degradation; E coli; Escherichia coli; GABA; Genomes; Glutamic acid; Health aspects; Inactivation; Lactococcus lactis; Life Sciences; Microbial Genetics and Genomics; Microbiology; Mutation; pH effects; Productivity; Substrates; γ-Aminobutyric acid
• ISSN: 0175-7598; 1432-0614
• DOI: 10.1007/s00253-018-8881-0

We previously developed a gamma-amino butyric acid (GABA)-producing strain of Escherichia coli , leading to production of 614.15 g/L GABA at 45 °C from L-glutamic acid (L-Glu) with a productivity of 40.94 g/L/h by three successive whole-cell conversion cycles. However, the increase in pH caused by the accumulation of GABA resulted in inactivation of the biocatalyst and consequently led to relatively lower productivity. In this study, by overcoming the major problem associated with the increase in pH during the production process, a more efficient biocatalyst was obtained through cascade modifications of the previously reported E. coli strain. First, we introduced four amino acid mutations to the codon-optimized GadB protein from Lactococcus lactis to shift its decarboxylation activity toward a neutral pH, resulting in 306.65 g/L of GABA with 99.14 mol% conversion yield and 69.8% increase in GABA productivity. Second, we promoted transportation of L-Glu and GABA by removing the genomic region encoding the C-plug of GadC (a glutamate/GABA antiporter) to allow its transport path to remain open at a neutral pH, which improved the GABA productivity by 16.8% with 99.3 mol% conversion of 3 M L-Glu. Third, we enhanced the expression of soluble GadB by introducing the GroESL molecular chaperones, leading to 20.2% improvement in GABA productivity, with 307.40 g/L of GABA and a 61.48 g/L/h productivity obtained in one cycle. Finally, we inhibited the degradation of GABA by inactivation of gadA and gadB from the E. coli genome, which resulted in almost no GABA degradation after 40 h. After the cascade system modifications, the engineered recombinant E. coli strain achieved a 44.04 g/L/h productivity with a 99.6 mol% conversion of 3 M L-Glu in a 5-L bioreactor, about twofold increase in productivity compared to the starting strain. This increase represents the highest GABA productivity by whole-cell bioconversion using L-Glu as a substrate in one cycle observed to date, even better than the productivity obtained from the three successive conversion cycles.